Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesA comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized single-blind study.
BMC Psychiatry, 06/01/09
Prosser JM et al. - This study can identify no difference in the efficacy of paroxetine and low-dose risperidone in the treatment of panic attacks. Low-dose risperidone appears to be tolerated equally well as paroxetine. Low-dose risperidone may be an effective treatment for anxiety disorders in which panic attacks are a significant component.
Methods- Fifty six subjects with a history of panic attacks were randomized to receive either risperidone or paroxetine.
- The subjects were then followed for eight weeks.
- Outcome measures included the Panic Disorder Severity Scale (PDSS), the Hamilton Anxiety Scale (Ham-A), the Hamilton Depression Rating Scale (Ham-D), the Sheehan Panic Anxiety Scale-Patient (SPAS-P), and the Clinical Global Impression scale (CGI).
- All subjects demonstrated a reduction in both the frequency and severity of panic attacks regardless of treatment received.
- Statistically significant improvements in rating scale scores for both groups were identified for the PDSS, the Ham-A, the Ham-D, and the CGI.
- There was no difference between treatment groups in the improvement in scores on the measures PDSS, Ham-A, Ham-D, and CGI.
- Post hoc tests suggest that subjects receiving risperidone may have a quicker clinical response than subjects receiving paroxetine.
Related Articles
Dont panic about statin side-effects
Internet Source, 11/11/09
Relevance Score: 64%
Update on Marijuana
Journal of Psychosocial Nursing and Mental Health Services, 10/26/09
Relevance Score: 64%
Identifying target groups for the prevention of anxiety disorders in the general population
Acta Psychiatrica Scandinavica, 10/15/09
Relevance Score: 64%
Anxiety and mood disorders in narcolepsy: a case-control study
General Hospital Psychiatry, 10/07/09
Relevance Score: 64%
The heart attack myth: Study establishes that women do have same the heart attack symptoms as men
EurekAlert, 10/26/09
Relevance Score: 45%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD: a systematic review and meta-analysis
European Respiratory Journal , 12/03/09
Beta-Blocker Therapy and Mortality of Patients with Chagas' Cardiomyopathy—a subanalysis of the REMADHE prospective trial
Circulation: Heart Failure, 12/03/09
Cizolirtine Citrate Is Safe and Effective for Treating Urinary Incontinence Secondary to Overactive Bladder: A Phase 2 Proof-of-Concept Study
European Urology, 12/03/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Lumbar nerve root pain: what works and what doesnt?
International Musculoskeletal Medicine, 12/03/09
Sleep and Biomarkers of Atherosclerosis in Elderly Alzheimer Caregivers and Controls
Gerontology, 12/03/09
Increased Cold-Pain Thresholds in Major Depression
The Journal of Pain, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor